BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17656348)

  • 21. [The clinical practice guidelines of the Sociedad Española de Cardiología on the automatic implantable defibrillator].
    Pérez-Villacastín J; Carmona Salinas JR; Hernández Madrid A; Marín Huerta E; Merino Llorens JL; Ormaetxe Merodio J; Moya i Mitjans A
    Rev Esp Cardiol; 1999 Dec; 52(12):1083-104. PubMed ID: 10659655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
    Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shouldn't everyone have an implantable cardioverter-defibrillator?
    Passman R; Kadish A
    Circulation; 2009 Dec; 120(22):2166-7. PubMed ID: 19917881
    [No Abstract]   [Full Text] [Related]  

  • 24. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator.
    Hohnloser SH; Gersh BJ
    Circulation; 2003 Feb; 107(7):941-6. PubMed ID: 12600904
    [No Abstract]   [Full Text] [Related]  

  • 26. Indications for implantable cardioverter-defibrillator placement in ischemic cardiomyopathy and after myocardial infarction.
    Mountantonakis SE; Hutchinson MD
    Curr Heart Fail Rep; 2011 Dec; 8(4):252-9. PubMed ID: 21769565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.
    Lim HS; Lip GY; Tse HF
    Europace; 2008 May; 10(5):536-9. PubMed ID: 18367548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter-defibrillators: a new preventive medical option.
    Glatter KA; Young JN; McElvany MD
    Prev Cardiol; 2006; 9(1):49-53; quiz 54-5. PubMed ID: 16407703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
    Valk S; Jordaens L
    Europace; 2009 Apr; 11(4):407-8. PubMed ID: 19279027
    [No Abstract]   [Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Implantable defibrillator. Update].
    Maury P; Schläpfer J; Metzger J; Delacrétaz E; Fromer M; Kappenberger L
    Rev Med Suisse Romande; 2001 Apr; 121(4):319-25. PubMed ID: 11400406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who needs and implantable cardioverter-defibrillator? ICDs save lives, but sometimes medications and other options make more sense.
    Harv Heart Lett; 2011 Jun; 21(10):4-5. PubMed ID: 21695859
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular implantable electronic devices in athletes.
    Do R; Patton KK
    Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Implantable cardioverter defibrillator].
    Tanaka S; Ikeshita M; Shoji T
    Kokyu To Junkan; 1993 Apr; 41(4):357-63. PubMed ID: 8516574
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sudden death: from epidemiology to therapeutic management-prevention].
    Aliot E
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():27-9. PubMed ID: 10949712
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audible implantable cardioverter defibrillator alarms detect intermittent conductor discontinuity.
    Sheth N; Mahmood K; Singh B; Carter-Adkins D; Pachulski RT
    Can J Cardiol; 2002 Apr; 18(4):430-2. PubMed ID: 11992137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [LifeVest - a novel treatment option prior to implantable cardioverter defibrillator].
    Mustafić H; Karimzadeh S; Park CI
    Rev Med Suisse; 2017 Mar; 13(552):500-504. PubMed ID: 28714616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.